Author Correction: Niche-derived Semaphorin 4A safeguards functional identity of myeloid-biased hematopoietic stem cells

Dorsa Toghani(Fred Hutch Cancer Center), Lev Silberstein(Massachusetts General Hospital), Sharon Zeng(Fred Hutch Cancer Center), Berthold Göttgens(Wellcome/MRC Cambridge Stem Cell Institute), Edie I. Crosse(MRC Centre for Regenerative Medicine), David M. Gravano(University of California, Merced), Atsushi Kumanogoh(The University of Osaka), Amogh Pradeep(Fred Hutch Cancer Center), Eric M. Pietras(University of Colorado Anschutz Medical Campus), Isabel Beerman(Boston Children's Hospital), Peter V. Kharchenko(Fleet Science Center), Sarah Kinston(University of Cambridge), Daniel C. Jones(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Claus Nerlov(John Radcliffe Hospital), Stefan Radtke(Fred Hutch Cancer Center), Sónia Rodríguez(City of Hope), Marion Mesnieres(KU Leuven), Jin‐Gyu Cheong(Memorial Sloan Kettering Cancer Center), Hans‐Peter Kiem(Fred Hutch Cancer Center), Joel A. Spencer(Massachusetts General Hospital), Le Zong(Peking University), Negar Seyedhassantehrani(University of California, Merced), Christian Burns(University of California, Merced), Christa Maes(KU Leuven), Antonio Scialdone(Helmholtz Zentrum München), Nadia Carlesso(City Of Hope National Medical Center), Thomas Worzfeld(Philipps University of Marburg), David T. Scadden(Harvard University), Elmir Mahammadov(Helmholtz Munich), Nicola K. Wilson(University of Cambridge), Bongsoo Park(National Institute on Aging), Ali Toghani(Fred Hutch Cancer Center), S. Gupte(Fred Hutch Cancer Center), Derek H. Janssens(Van Andel Institute), Steven Z. Josefowicz(Cornell University), Fabienne Lucas(Brigham and Women's Hospital)
Nature Aging
February 20, 2025
Cited by 0


Related Papers